It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Quantification of antibiotic utilization is an essential component of antibiotic stewardship programs. In this multicentric study, we used different metrics to evaluate inpatient antibiotic use in children. The study objectives were to describe point prevalence of antibiotic use by indication and patient characteristics, to evaluate DOTs, LOTs and PDDs, and to compare PDDs to DDDs, which assume average maintenance dose per day in adults. All children hospitalized on the days of the study were included. Trained personnel collected demographic and clinical data from patients’ clinical records. We recorded information about antibiotics administered on the date of data collection, and in the previous 30 days of hospitalization. Of 810 patients, 380 (46.9%; CI 95%: 43.4–50.4) received one or more antibiotics; prevalence of use was 27.0% for prophylaxis (219/810), and 20.7% (168/810) for treatment. Overall, 587 drugs were issued to the 380 patients receiving antibiotics (1.5 antibiotic per patient). When considering treatments, DOT and LOT per 100 patient-days were 30.5 and 19.1, respectively, resulting in a DOT/LOT ratio of 1.6. PDDs increased with age and approached DDDs only in children aged ≥ 10 years; the ratio between PDDs estimated in children aged ≥ 10 years and in 0–11 month-old infants ranged from 2 for sulfamethoxazole and trimethoprim, to 25 for meropenem. Our results confirm that DOT, LOT and PDD are better alternatives to DDD in children.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Bambino Gesù Children’s Hospital, Clinical Pathways and Epidemiology Unit, Rome, Italy (GRID:grid.414125.7) (ISNI:0000 0001 0727 6809)
2 University of Turin, Department of Public Health and Pediatrics, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580)
3 University of Foggia, Ospedale “D’Avanzo” Policlinico Riuniti, Department of Medical and Surgical Sciences, Foggia, Italy (GRID:grid.10796.39) (ISNI:0000000121049995)
4 Ospedale Infantile Regina Margherita - AOU Città Della Salute E Della Scienza Di Torino, Torino, Italy (GRID:grid.415778.8)
5 Ospedale dei Bambini - ASST Degli Spedali Civili di Brescia, Brescia, Italy (GRID:grid.412725.7)
6 Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Ospedale Pediatrico “Giovanni XXIII”, Bari, Italy (GRID:grid.488556.2)
7 Regional Health and Social Agency, Emilia-Romagna Region, Italy (GRID:grid.488556.2)
8 Bambino Gesù Children’s Hospital, Medical Direction, Rome, Italy (GRID:grid.414125.7) (ISNI:0000 0001 0727 6809)